Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Urinary Tract Infection Treatment Market


6. Market Share - Global Urinary Tract Infection Treatment Market

6.1 By Type
6.2 By Disease Type
6.3 By Regions


7. Type - Global Urinary Tract Infection Treatment Market

7.1 Quinolones
7.2 B-lactam Cephalosporins
7.3 Aminoglycosides
7.4 Penicillin
7.5 Azoles
7.6 Others


8. Disease Type - Global Urinary Tract Infection Treatment Market

8.1 Uncomplicated
8.2 Complicated UTI
8.3 Others


9. Regions- Global Urinary Tract Infection Treatment Market

9.1 America
9.2 Europe
9.3 Asia Pacific
9.4 MEA


10. Porters Five Forces

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. Company Analysis

11.1 Novartis AG

11.1.1 Company Profile
11.1.2 Recent Developments
11.1.3 Revenue

11.2 Allergan

11.2.1 Company Profile
11.2.2 Recent Developments
11.2.3 Revenue

11.3 Bayer HealthCare Pharmaceuticals

11.3.1 Company Profile
11.3.2 Recent Developments
11.3.3 Revenue

11.4 Astrazeneca

11.4.1 Company Profile
11.4.2 Recent Developments
11.4.3 Revenue

11.5 GlaxoSmithKline PLC

11.5.1 Company Profile
11.5.2 Recent Developments
11.5.3 Revenue

11.6 Pfizer

11.6.1 Company Profile
11.6.2 Recent Developments
11.6.3 Revenue

11.7 Merck & Co., Inc

11.7.1 Company Profile
11.7.2 Recent Developments
11.7.3 Revenue

11.8 Bristol-Myers Squibb Company

11.8.1 Company Profile
11.8.2 Recent Developments
11.8.3 Revenue



List of Figures

Figure-01: Global – Urinary Tract Infection Treatment Market (Billion US$), 2018 – 2021
Figure-02: Global – Forecast for Urinary Tract Infection Treatment Market (Billion US$), 2022 – 2027
Figure-03: Type – Quinolones Market (Million US$), 2017 – 2021
Figure-04: Type – Forecast for Quinolones Market (Million US$), 2022 – 2027
Figure-05: Type – B-lactam Cephalosporins Market (Million US$), 2017 – 2021
Figure-06: Type – Forecast for B-lactam Cephalosporins Market (Million US$), 2022 – 2027
Figure-07: Type – Aminoglycosides Market (Million US$), 2017 – 2021
Figure-08: Type – Forecast for Aminoglycosides Market (Million US$), 2022 – 2027
Figure-09: Type – Penicillin Market (Million US$), 2017 – 2021
Figure-10: Type – Forecast for Penicillin Market (Million US$), 2022 – 2027
Figure-11: Type – Azoles Market (Million US$), 2017 – 2021
Figure-12: Type – Forecast for Azoles Market (Million US$), 2022 – 2027
Figure-13: Type – Others Market (Million US$), 2017 – 2021
Figure-14: Type – Forecast for Others Market (Million US$), 2022 – 2027
Figure-15: Disease Type – Uncomplicated Market (Million US$), 2017 – 2021
Figure-16: Disease Type – Forecast for Uncomplicated Market (Million US$), 2022 – 2027
Figure-17: Disease Type – Complicated UTI Market (Million US$), 2017 – 2021
Figure-18: Disease Type – Forecast for Complicated UTI Market (Million US$), 2022 – 2027
Figure-19: Disease Type – Others Market (Million US$), 2017 – 2021
Figure-20: Disease Type – Forecast for Others Market (Million US$), 2022 – 2027
Figure-21: America – Urinary Tract Infection Treatment Market (Million US$), 2017 – 2021
Figure-22: America – Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 – 2027
Figure-23: Europe – Urinary Tract Infection Treatment Market (Million US$), 2017 – 2021
Figure-24: Europe – Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 – 2027
Figure-25: Asia Pacific – Urinary Tract Infection Treatment Market (Million US$), 2017 – 2021
Figure-26: Asia Pacific – Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 – 2027
Figure-27: Middle-East & Africa – Urinary Tract Infection Treatment Market (Million US$), 2017 – 2021
Figure-28: Middle-East & Africa – Forecast for Urinary Tract Infection Treatment Market (Million US$), 2022 – 2027
Figure-29: Novartis AG – Global Revenue (Million US$), 2017 – 2021
Figure-30: Novartis AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-31: Allergan – Global Revenue (Million US$), 2017 – 2021
Figure-32: Allergan – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-33: Bayer HealthCare Pharmaceuticals – Global Revenue (Million US$), 2017 – 2021
Figure-34: Bayer HealthCare Pharmaceuticals – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-35: Astrazeneca – Global Revenue (Million US$), 2017 – 2021
Figure-36: Astrazeneca – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-37: GlaxoSmithKline PLC – Global Revenue (Million US$), 2017 – 2021
Figure-38: GlaxoSmithKline PLC – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-39: Pfizer – Global Revenue (Million US$), 2017 – 2021
Figure-40: Pfizer – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-41: Merck & Co., Inc – Global Revenue (Million US$), 2017 – 2021
Figure-42: Merck & Co., Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: Bristol-Myers Squibb Company – Global Revenue (Million US$), 2017 – 2021
Figure-44: Bristol-Myers Squibb Company – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Urinary Tract Infection Treatment Market Share by Type (Percent), 2017 – 2021
Table-02: Global – Forecast for Urinary Tract Infection Treatment Market Share by Type (Percent), 2022 – 2027
Table-03: Global – Urinary Tract Infection Treatment Market Share by Disease Type (Percent), 2018 – 2021
Table-04: Global – Forecast for Urinary Tract Infection Treatment Market Share by Disease Type (Percent), 2022 – 2027
Table-05: Global – Urinary Tract Infection Treatment Market Share by Region (Percent), 2017 – 2021
Table-06: Global – Forecast for Urinary Tract Infection Treatment Market Share by Region (Percent), 2022 – 2027